Technische Universität Dresden

Phase III post-neoadjuvant study evaluating sacituzumab govitecan (SG), an antibody drug conjugate in primary HER2-negative breast cancer patients with high relapse risk after standard neoadjuvant treatment: SASCIA (2021) Marme F, Hanusch C, Furlanetto J, Denkert C, Link T, Untch M, Blohmer JU, et al. Conference contribution A multicenter, randomized, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (mBC) (DESIREE) (2021) Loibl S, Schmidt M, Luebbe K, Decker T, Thill M, Bauer L, Mueller V, et al. Conference contribution The mediating role of COVID-19-related burden in the association between adverse childhood experiences and emotional exhaustion: results of the egePan - VOICE study (2021) Clemens V, Beschoner P, Jarczok MN, Weimer K, Kempf M, Morawa E, Geiser F, et al. Journal article Bereitschaft zur COVID-19-Impfung unter Beschäftigten im Gesundheitswesen in Deutschland (2021) Schug C, Erim Y, Geiser F, Hiebel N, Beschoner P, Jerg-Bretzke L, Albus C, et al. Journal article Reduction in Earning Capacity (MdE) for work-related Skin Cancer MdE Tables for BK Numbers 5102 and 5103 (2021) Krohn S, Skudlik C, Bauer A, Bernhard-Klimt C, Dickel H, Drexler H, Elsner P, et al. Journal article Legal Changes in Occupational Diseases - Effects on the Assessment of the Reduction in Earning Capacity (MdE) in the case of work-related Skin Diseases within the Meaning of BK No. 5101 Case Studies and new Obligations to Cooperate (2021) Krohn S, Skudlik C, Bauer A, Bernhard-Klimt C, Dickel H, Drexler H, Elsner P, et al. Journal article Electronic module assembly (2021) Franke J, Wang L, Bock K, Wilde J Journal article Erratum zu Mitteilungen der Deutschen Gesellschaft für Pathologie (Der Pathologe, (2021), 42, 3, (352-353), 10.1007/s00292-021-00931-y) (2021) Joehrens K, Baretton G, Schildhaus HU, Agaimy A, Scheel A, Schwammborn K, Laenger F, et al. Journal article, Erratum Quality of life of GIST patients with and without current tyrosine kinase inhibitor treatment: Cross-sectional results of a German multicentre observational study (PROSa) (2021) Eichler M, Pink D, Menge F, Jakob J, Hentschel L, Richter S, Hohenberger P, et al. Journal article Efficacy of temporally intensified exposure for anxiety disorders: A multicenter randomized clinical trial (2021) Pittig A, Heinig I, Goerigk S, Thiel F, Hummel K, Scholl L, Deckert J, et al. Journal article